Remove Events Shows-Conferences
article thumbnail

Reaching New Global ‘Frontiers’ In Life Sciences

Intouch Solutions

Last week, Frontiers Health, the premier global digital health innovation event, was held in Rome, Italy. The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare.

article thumbnail

Event Marketing in the Digital Age: Pharma Industry Insights

Pharma Marketing Network

Event marketing is a form of marketing that involves face-to-face interactions between a brand or product and potential customers. In the digital age, event marketing is becoming increasingly important for companies in the pharmaceutical industry. What is Event Marketing?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Keynotes announced for Research and Innovation 2024

Drug Discovery World

There will also be a trade show and exhibition, a poster competition, and networking opportunities. TechBio Breakthrough Zone ELRIG will also be launching the TechBio Breakthrough Zone at Research & Innovation 2024.

article thumbnail

Disrupted medical conferences: Lessons learnt

pharmaphorum

The COVID-19 pandemic has radically disrupted traditional medical society conferences in a way that could scarcely have been imagined in 2019. The vast majority of societies were able to transition their planned physical events to virtual formats within remarkably short periods of time, and some delivered impressive attendee experiences.

Doctors 105
article thumbnail

#ASH22: Frontline Imbruvica threatens transplant use in a MCL patient subset

Pharmaceutical Technology

BTK inhibitors such as AbbVie’s /Janssen’s Imbruvica (ibrutinib) are SOC for relapsed/refractory (R/R) MCL patients, and previous data from the Phase III SHINE study in older MCL patients showed that the addition of Imbruvica to a rituximab-based chemotherapy regimen in the first line can confer a progression-free survival (PFS) advantage.

HR 130
article thumbnail

ACI’s 37th Annual FDA Boot Camp (Virtual Conference)

FDA Law Blog

The American Conference Institute’s (“ACI’s”) popular “ FDA Boot Camp ” – now in its 37th iteration – is scheduled to take place from September 29-30, 2021 (Eastern Standard Time). The conference is billed as the premier event to provide folks with a roadmap to navigate the difficult terrain of FDA regulatory law.

article thumbnail

What we heard and saw at HLTH22, with Matthew Holt – the pharmaphorum podcast

pharmaphorum

pharmaphorum Editor-in-Chief Jonah Comstock travelled to Las Vegas last week with thousands of other healthcare stakeholders for the HLTH 2022 conference. In three days of sessions, attendees heard from some of the biggest voices in the healthcare industry, big tech, and U.S. government.